Robotic surgery moves to volume buying as Singapore, India and England add machines

Two new platforms, two countries, one week

Farrer Park Hospital said its surgeons completed two robotic-assisted urology procedures with the Edge MP1000. Clinical use began on 23 September 2026. Both patients recovered as expected, with no complications, the hospital said.

Farrer Park gave no further case numbers beyond those two procedures. More hospitals running more than one robot platform give buyers a second supplier. In principle, that means a lower price per procedure. But none of these announcements discloses cost per operation.

The hospital framed the launch around its tenth anniversary and value-based care. "Robotic surgery should not be a premium reserved for a few," executive chairman Maurice Choo said. He added that the platform is meant to widen access to minimally invasive surgery while keeping costs accessible. Farrer Park said the MP1000 will be used across several specialities by trained surgeons. Edge Medical makes the robot, and distributor idsMED supplies it. It said outcomes would match existing market-leading systems. It gave no cost comparison with the robots it already runs.

Apollo Hospitals Bannerghatta Road in Bengaluru introduced the Da Vinci 5 from Intuitive.

The hospital said the system is already in use across cardiac, oncology, gynaecological, gastrointestinal and urology surgery. It highlighted Force Feedback. This lets surgeons sense the pressure applied to tissue when using compatible instruments. The announcement also listed more than 150 technological enhancements, including 3D imaging and a redesigned console. It published no outcome figure. The headline called the operation India's first Da Vinci 5 surgery. The hospital's own statement described it as being amongst the first few hospitals in the country to introduce the system.

England puts public money behind volume

The Autumn Budget on Wednesday 28 October put £100m behind robotically assisted surgery in England.

That sits beside £190m of additional winter funding for 2026-27. The government's stated aim is to lift robotic procedures from 70,000 a year to 500,000 by 2035. That is roughly seven times current volume. The same Budget commissioned an independent review of NHS productivity and the opportunities offered by AI and other technologies. Mark Bailie, chair of NHS England's Digital, leads it. It is due to report in early 2027 and will feed the next spending review.

The £100m is the smaller line. But it is the one that changes purchasing behaviour. It pays for adoption, not for keeping wards open.

The operating table problem nobody budgets for

New machines bring costs that rarely appear in a procurement notice. Gentherm Medical launched its ThermAffyx Patient Safety System at the AORN Global Surgical Conference this year. The system combines patient warming and secure positioning for robot-assisted surgery.

Adam Hauke, Gentherm's global director for product strategy and innovation, told The Robot Report that clinicians had said almost all of their robotics patients are hypothermic. Robot-assisted cases often keep patients tilted head-down for long periods. The robot occupies the space over-body warming would use. Under-body warming then clashes with the pads that hold the patient still. Hauke said warming and positioning "are no longer separate considerations" and "are competing for the same real estate".

He also said patient movement on the table is not tracked. Teams notice it mainly through tension on the robotic instruments, he said.

What the evidence base actually looks like

The clinical argument is running in parallel. It does not always favour the hardware. A. Marc Gillinov of Cleveland Clinic used a Stanford lecture on 28 September 2026 to press for scrutiny of evidence on surgical innovation. He also argued for recommendations tailored to each patient.

Gillinov presented a retrospective study. In it, patients who received transcatheter edge-to-edge repair did not fare as well as those who had surgery. He called for more comparative effectiveness trials. He also described why those trials are hard. "Surgery is highly variable and very operator dependent," he said. Cleveland Clinic is enrolling patients in the PRIMARY Trial. The trial compares transcatheter mitral valve repair using MitraClip with surgical mitral valve repair.

That is a randomised comparison. The hospital launches offer case counts and feature lists.

What to watch

Farrer Park has not said how many MP1000 procedures it expects to run. It has not said what it will charge patients relative to existing platforms. Apollo has not disclosed what the Da Vinci 5 installation cost. It has not said how many surgeons are trained on it. It said training underpins the rollout.

The NHS review is the next hard date. Its report is due in early 2027 and will feed the spending review. There, the 500,000-procedure target would be funded or dropped.